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Natriuretic peptide receptors A and B have different cellular distribu-
tions in rat kidney. The cellular distribution of guanylyl cyclase coupled
natriuretic peptide receptors type A (GC-A) and type B (GC-B) was
examined by immunocytochemistry in normal rat kidney, and compared
with the distribution of the vacuolar H-ATPase. Staining for GC-A was
found in glomeruli, thin limbs of Henle's loop, cortical collecting tubule,
and inner medullaty collecting duct. Staining for GC-B was found in
glomeruli and the same nephron sections as GC-A, with the exception of
the thin limbs. In the cortical collecting tubule, GC-A was found in both
principal and intercalated cells; GC-B was restricted to the apical pole of
a intercalated cells. In inner medullary collecting ducts cells, GC-A was
located on the basal membrane, whereas GC-B was found in the apical
pole. The different pattern of polarization of natriuretic peptide receptors
in the inner medulla provides a plausible basis for the different physiologic
effects of atrial natriuretic factor and C-type natriuretic peptide. The
results also suggest the possibility that GC-B is involved in the regulation
of bicarbonate transport in the cortical collecting tubule.
The natriuretic peptide receptor family consists of three types
of receptors [1]. Guanylyl cyclase receptor A (GC-A) preferen-
tially binds atrial natriuretic factor (ANF) and brain natriuretic
peptide (BNP) [2—4]; guanylyl cyclase receptor B (GC-B) binds
more selectively to C-type natriuretic peptide (CNP) [1. Upon
binding of their ligands, both GC-A and GC-B generate cGMP,
the principal second messenger of the natriuretic peptide system
[2—4]. The third family member, the natriuretic peptide clearance
receptor (NP-C), has no measurable guanylyl cyclase activity, and
binds to all natriuretic peptides [1].
The ligands for the guanylyl cyclase-coupled receptors have
different physiologic effects in the kidney. Atrial natriuretic pep-
tide has potent natriuretic effects, which are thought to be
mediated by both an increase of glomerular filtration rate and
inhibition of sodium reabsorption in the cortical and inner
medullary collecting duct [5—7]. In contrast, CNP has only weak or
negligible natriuretic effects [8]. The reasons for the failure of
CNP to produce a natriuresis are currently unknown.
The physiologic effects of the natriuretic peptides depend, in
part, on the distribution of their receptors. Several prior studies
attempted to determine the location of guanylyl cyclase-coupled
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receptors in the nephron. GC-A receptors were found in glomer-
uli and inner medulla by radioligand binding studies [9]. With
more sensitive methods, such as measurement of guanylyl cyclase
activity in microdissected tubules [10], or reverse transcription of
RNA followed by polymerase chain reaction (RT-PCR) [111,
GC-A and its messenger RNA were found in several other
segments of the nephron, with the highest levels observed in
medullary thin limbs and cortical collecting tubule.
Several methods have been used to examine the location of
GC-B receptors in the kidney. A radioligand binding study using
a 1251-tyrosine-CNP analog demonstrated GC-B receptors only in
glomeruli, and these were attributed to natriuretic peptide clear-
ance receptors [12]. The failure to find CNP binding at other sites
may have occurred because the tyrosine-CNP analogues have a
lower affinity for the GC-B receptor than does native CNP [13].
Messenger RNA for GC-B was reported in renal cortical and
medullary membrane fractions [14]. In recent studies using RT-
PCR of mRNA for GC-B from microdissected sections of
nephrons, the highest levels of GC-B message were found in
glomerulus, cortical and medullary collecting duct and medullary
thick ascending limb [15, 16]. The distribution of CNP-stimulated
cGMP formation in microdissected tubules was similar to the
distribution of GC-B mRNA [151, suggesting that the level of
receptor mRNA in different segments was indicative of the
quantity of functional GC-B receptor.
In the present study, we used antibodies specific for GC-A and
GC-B to determine the distribution of these receptors in the
nephron, and the specific cell types which express them. We
demonstrate that GC-A and GC-B have different distributions in
the kidney, and the location of the receptors provides insight into
the basis for the different physiologic effects of ANF and CNP.
Methods
Kidneys from nonfasted anesthetized Sprague-Dawley rats
weighing between 250 and 300 g were perfused with normal saline
via the abdominal aorta. Kidneys were halved, fixed in Bouin's
solution (Sigma Chemical Co.; St. Louis, MO, USA), embedded
in paraffin, and sectioned. After removal of paraffin, kidney
sections were processed for fluorescent immunocytochemistry.
Briefly, sections were hydrated, stained with hematoxylin (Sigma),
and then preincubated with 20% normal goat serum in phosphate
buffered saline for two hours to reduce nonspecific background
staining.
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Fig. 1. Immunocytochemical localization of H-ATPase, GC-A, and GC-B in rat cortex. Sections were double-labeled either with anti-H-ATPase plus
anti-GC-A antibody or anti-H-ATPase plus anti-GC-B antibody. Secondaiy antibodies labeled with Texas Red and fluorescein were used to detect
the H-ATPase and the natriuretic peptide receptors, respectively. Panels: a and c, H-ATPase; b, GC-A; d, GC-B. Renal structures are indicated: g =
glomerulus; curved arrow = proximal tubule; small arrow = connecting tubule; large arrow = cortical collecting tubule; bent arrow in panels C and D
= intercalated cells in cortical collecting tubule with diffuse or basolateral H-ATPase staining. Magnification = 800x.
The primary antibodies used were rabbit antisera R1214,
directed against GC-A, and Z657, directed against GC-B (provid-
ed by Dr. D. Garbers, Howard Hughes Medical Institute, Univer-
sity of Texas Southwestern, Dallas, TX, USA). Antiserum R1214
was shown to immunoprecipitate GC-A from GC-A-transfected
human embryonic fibroblast 293 cells; the immunoprecipitation
was inhibited completely by a synthetic peptide corresponding to
the carboxyl terminal amino acid sequence of the receptor [17].
Antiserum Z657 binds specifically to the carboxyl terminus of the
GC-B receptor. We confirmed that both GC-A and GC-B antisera
immunoprecipitate proteins with a molecular weight of approxi-
mately 130 kD from rat kidney tissue extracts (data not shown).
The anti-GC-A receptor antibody does not bind to a synthetic
pepticle identical to the carboxyl terminal amino acid sequence of
the GC-B receptor, nor does the antiserum to GC-B react with
peptide from the GC-A receptor (D.L. Garbers, personal com-
munication). Monoclonal antibody Eli, directed against the 31
kD subunit of bovine vacuolar H-TPase, was described and
characterized previously [18, 19].
The kidney sections were incubated overnight with undiluted
supernatant from hybridoma cell cultures containing antibody
Eli, and with 1:200 dilutions of rabbit polyclonal antiserum
R1214 or Z657. After three rinses in phosphate buffered saline,
samples were incubated for 30 minutes with fluorescein isothio-
cyanate-labeled goat anti-rabbit IgG (Fisher Scientific, Pittsburgh,
PA) and with Texas Red-labeled goat anti-mouse IgG (Fisher),
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Fig. 2. Immunocytochemical localization of H-ATPase, GC-A and GC-B in the rat glomerulus. Sections were double-labeled either with anti-H-
ATPase plus anti-GC-A antibody, or anti-H-ATPase plus anti-GC-B antibody, and secondary antibodies as in Figure 1. Controls were generated by
incubation of sections with anti-GC-A or anti-GC-B antibody in the presence of the corresponding synthetic receptor peptide. Panels: a, H-ATPase;
b, GC-A; c, control for GC-A. Panels: d, H-ATPase; e, GC-B; f, control for GC-B. Magnification = 1000X.
each diluted 1:50 in 20% normal goat serum. Sections were
washed with PBS and mounted in 60% glycerol containing 0.025%
para-phenylene diamine, and examined with a Nikon epifluores-
cence microscope. Photographs of sections were taken with
Kodak Ektachrome slide film.
Results
No staining of glomeruli or collecting ducts was observed in
sections that were incubated with non-immune serum or with
antiserum in the presence of 500 g/ml of synthetic peptide
corresponding to the C-terminal amino acid sequence of either
GC-A or GC-B receptor (Fig. 2 c, f and Fig. 5 c, f).
Glomeruli
Glomeruli were stained with both the GC-A and GC-B anti-
bodies (Figs. 1 and 2). The glomerular staining for GC-A was
diffuse, in a pattern suggesting that it was staining the mesangial
or visceral epithelial cells (Figs. lB and 2B). Glomerular staining
for GC-B receptors was more punctate, and did not correspond to
any identifiable anatomic structure (Figs. id and 2e). No H-
ATPase staining was observed in the glomerulus (Fig. 2 a, d), as
noted previously [18—201.
Proximal tubule
No staining for GC-A (Fig. ib) or GC-B (Fig. Id) was detected
in proximal convoluted or straight tubules. Brush border mem-
branes of the proximal tubules were labeled intensely with H-
ATPase antibody (Fig. 1 a, c) as described [18—20].
Loop of Henle
The thin limbs of the loop of Henle stained for GC-A receptors
throughout the inner medulla (Fig. 6c). The staining appeared
primarily in the apical membrane. In contrast, no staining for
GC-B was found in the loop of Henle (Fig. Se). The inner
medullary portion of the thin limbs did not stain with H-ATPase
antibodies, as previously noted [20].
No specific staining for GC-A (Fig. 4b) or GC-B (Fig. 4d) was
found in the epithelial cells of the outer medullary thick ascending
limbs. Staining for GC-A was observed, however, in areas adja-
cent to the thick ascending limbs and collecting ducts (Fig. 4b),
corresponding to the location of the capillary plexus [211. Weak
apical staining for H-ATPase was described previously in thick
ascending limbs [20], but was absent in our sections.
Cortical collecting tubule
Intercalated cells represent about 40% of the cells in the
connecting tubule and cortical collecting tubule [20, 22—241, and
were distinguished from principal cells by their staining for
H-ATPase (Fig. 1 a, c, and Fig. 3 a, c). Intense labeling with
GC-B antibodies was found in most, but not all intercalated cells,
and was absent from principal cells (Figs. id and 3d). Staining for
GC-A was also found in some intercalated cells, but was not
observed as frequently as that for GC-B. GC-A staining was not
restricted to intercalated cells, however, and was observed fre-
quently on principal cells (Figs. lb and 3b). The staining for both
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Fig. 3. Immunocytochemical localization of HtATPase, GC-A and GC-B in the rat cortical collecting tubule. Sections were double-labeled either with
anti-H-ATPase plus anti-GC-A antibody or anti-H-ATPase plus anti-GC-B antibody as in Figure 1. Panels: a and C: HtATPase; b, GC-A; d, GC-B.
Large arrows = cortical collecting tubule; small arrows = intercalated cells with diffuse H-ATPase staining. Magnification = 1600X.
GC-A and GC-B was located in the apical pole of the epithelial
cells.
Previous studies demonstrated that intercalated cells may have
apical, basal, or diffuse intracellular distributions of the vacuolar
H-ATPase, likely reflecting the phenotype of the cells as a or /3
intercalated cells [19, 20, 24-.26]. (The a and /3 cells correspond,
respectively, to type A and type B intercalated cells [231; the a and
/3 nomenclature is used as proposed by Schuster [24]. Emmons
and Kurtz [27] have described a third functional type of interca-
lated cell, the y cell, in rabbit cortical collecting duct; it is
presently unknown whether such cells are present in rat kidney.)
Staining for GC-B was found most often in intercalated cells with
apical H-ATPase staining (a intercalated cells), and was rarely
observed itt intercalated cells with diffuse or basal staining (/3
intercalated cells; Figs. id and 3d).
Medullaiy collecting duct
In the outer medullary collecting duct, staining for GC-B was
again restricted to intercalated cells, and was located in the apical
pole (Fig. 4d); no GC-A staining was detected (Fig. 4b). In the
Outer third of the inner medullary collecting duct, apical staining
for both GC-A and GC-B was found in some intercalated cells
(Fig. 5 b, e), although these cells were sparse. In this segment,
intense staining for GC-A was observed on the basal membrane of
the inner medullary collecting duct epithelial cells (Fig. 5b). In the
middle third of the inner medulla, the polarity of staining for
GC-A was gradually lost, and in the inner third, GC-A staining
was distributed diffusely within most epithelial cells, with a cell
exhibiting apical GC-A labeling (Fig. 6c). Staining for GC-B was
observed in inner medullary collecting duct cells along the entire
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Fig. 4. Immunocytochemical localization of H-A TPase, GC-A and GC-B in the rat kidney Outer medulla (inner stripe). Sections were double-labeled
either with anti-H-ATPase plus anti-GC-A antibody or anti-H-ATPase plus anti-GC-B antibody as in Figure 1. Panels: A and C, HtATPase; B,
GC-A; D, GC-B. Large arrow = collecting duct; curved arrow = medullary thick ascending limb; small arrow = capillary plexus. Magnification = 1600X.
length of the inner medulla. In contrast to that for GC-A, most of
the GC-B labeling was found in the apical pole of the inner
medullary collecting duct cells (Fig. 5e).
Discussion
ANF and BNP have potent natriuretic and vasodilatory prop-
erties [28]. CNP was initially purified on the basis of its ability to
relax chicken rectum smooth muscle [8], and its potency as an
arterial vasodilator is similar to that of ANF [29]. Since CNP is
synthesized by endothelial cells and GC-B is present on arterial
smooth muscle cells [30], CNP may function as a paracrine
modulator of vascular tone.
Much less is known, however, about the roles of CNP and GC-B
in the kidney. Intravenous infusion of CNP into rats produced a
natriuresis only at doses several orders of magnitude higher than
needed with ANF [8]. With intravenous infusion of equimolar
doses of CNP and ANF in the dog, ANF produced a significant
increase in GFR and UNaV, but CNP actually decreased sodium
excretion [29].
Several mechanisms might contribute to the failure of CNP to
produce a natriuresis. First, there is evidence that CNP stimulates
less cGMP formation in the kidney than does ANF. Cyclic GMP
generation in isolated glomeruli was significantly lower with CNP
than with equimolar concentrations of ANF [12], and the amount
of cGMP produced in isolated rat nephron segments following the
stimulation with CNP was one quarter to one half of that observed
with identical concentrations of ANF [15]. Since numbers of
GC-B and GC-A receptors have not been measured directly in the
kidney, it is unclear whether the blunted response to CNP is due
to a lower receptor density, or to an intrinsic difference in receptor
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Fig. 5. Immunocytochemical localization of HtATPase, GC-A and GC-B in the outer third of inner medulla. Sections were double-labeled either with
anti-H-ATPase plus anti-GC-A antibody or anti-H-ATPase plus anti-GC-B antibody as in Figure 1. Controls were generated as in Figure 2. Panels:
a, H-ATPase; b, GC-A; c, control for GC-A. Panels: d, HtATPase; e, GC-B; f, control for GC-B. Long arrows = lumina of collecting ducts; curved
arrows = basal membrane of collecting duct epithelial cells. Magnification = i000x.
guanylyl cyclase activity. Our studies do not clarify this issue, since
the immunocytochemical assays for GC-B and GC-A used here do
not allow receptor density to be quantified accurately.
A second possible mechanism for the modest natriuretic effect
observed with CNP is that GC-B and GC-A receptors have
different distributions in the kidney, and that GC-B is absent from
sodium transporting cells. Messenger RNA for GC-B has been
detected in most nephron segments expressing GC-A, except for
the thin limbs, which express mRNA for GC-A but not GC-B [11,
15]. In the present study, we confirm these findings by demon-
strating that both the GC-A and GC-B receptor proteins are
present in glomeruli, the cortical collecting tubule, and the inner
medullary collecting duct cells, but that only GC-A protein is in
the thin limbs. Both mRNA for GC-A and GC-B [11, 15, 16] and
guanylyl cyclase activity [10, 151 have been found in the medullary
thick limb. We were unable to detect GC-A or GC-B protein in
the medullary thick ascending limbs, but since high background
staining was present in this region, we cannot exclude the possi-
bility that natriuretic peptide receptors are present in this seg-
ment.
It is unlikely that the presence of GC-A in the thin limb is the
basis for the functional differences between CNP and ANF, since
the thin limb is probably not the principal site for the natriuretic
effect of ANF [6, 28]. ANF is thought to produce a natriuresis by
inhibiting sodium reabsorption in the inner medullary collecting
duct [6, 28]. In the outer third of the inner medullary collecting
duct, we found that GC-A was located in the basal membrane of
the epithelial cells, where, presumably, it is accessible to circulat-
ing ANF. In contrast, we found that GC-B was located primarily
in the apical pole of the inner medullary collecting duct cells,
where it may not be available to circulating peptide.
Filtered CNP may be inaccessible to luminal GC-B receptors as
well. Filtered ANF is degraded by a neutral endopeptidase which
is abundant in the proximal tubule brush border [31]. CNP is
inactivated by the same neutral endopeptidase [32], and therefore
filtered CNP may be degraded before arrival in the lumen of the
collecting duct. The intracellular distribution of CNP receptors in
the inner medullary collecting duct cells, and the likely degrada-
tion of filtered CNP, offer a plausible explanation for its weak
natriuretic effect.
If circulating CNP does not control sodium reabsorption, what
might be the role of GC-B receptors in the kidney? Our labora-
tory [33, 34] and others [35, 36] have shown that natriuretic
peptides ANF and CNP are synthesized in the kidney. Since CNP
is synthesized in the proximal tubule, thick ascending limb, and
inner medullary collecting duct [34], it is possible that CNP is
secreted into the lumen of the nephron from these sites. Thus,
luminal CNP should have access to GC-B receptors in the inner
medullary collecting duct. Therefore, CNP may function as a
paracrine modulator of sodium transport in the inner medullary
collecting duct.
Immunocytochemical studies have localized ANF to the apical
pole of intercalated cells in the collecting duct of human [371 and
rat [38] kidney. CNP has also been found in intercalated cells [34].
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Fig. 6. Section of the inner third of the inner
medulla, a. Light microscopic view of vasa recta
with erythrocytes in the lumina (small arrow).
b. Section stained for H-ATPase. c. Same
section stained for GC-A. Long arrow = thin
limb; large arrow = collecting duct; bent arrow
= collecting duct with apical cellular staining.
Magnification = 1800X.
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GC-A and GC-B are also found in intercalated cells, suggesting
that the natriuretic peptides could have autocrine effects. Inter-
calated cells are responsible for both bicarbonate secretion and
proton secretion in the cortical collecting duct [24, 39]. Our
finding that GC-B receptors are present in intercalated cells but
not principal cells suggests that CNP may have a role in regulating
bicarbonate transport. Although 13 adrenergic agonists and other
agents that stimulate cAMP have been found to affect collecting
duct bicarbonate secretion [40—42], few hormonal factors have
been found to affect proton secretion [43, We found that
GC-B was located predominantly in cells with HATPase in the
apical pole, likely a intercalated cells, indicating that CNP might
have the capacity to modify proton secretion. Tojo et al have
demonstrated recently that dibutyryl cyclic GMP, a permeable
analog of cGMP, and agents that activate soluble guanylyl cyclase
through nitric oxide inhibit bafilomycin A1-sensitive ATPase
activity in rat cortical collecting duct [45], which has been sug-
gested to be a measure of proton pump activity.
In summary, we have determined the distribution of GC-A and
GC-B guanylyl cyclase-coupled receptors in rat kidney. The
cellular location of GC-B in inner medullary collecting duct
provides an explanation for the failure of CNP to elicit a
natriuresis. In the cortical collecting tubule, the expression of
GC-B, but not that of GC-A, is restricted to intercalated cells,
suggesting the possibility that the CNP/GC-B natriuretic peptide
system might participate in acid-base homeostasis.
Acknowledgments
We thank Dr. David Garbers for providing us with antibodies to the
GC-A and GC-B receptors. This work was supported by NIH grants
AR32087, DK38848, DK09976, DK 45181, and training grant DK07126.
Reprint requests to Detlef Ritter, M.D., Department of Pathology, St. Louis
University School of Medicine, 1402 5. Grand Ave., St. Louis, Missouri
63104, USA.
References
1. SUGA 5, NAKAO K, HOSODA K, MUKOYAMA M, OGAWA Y, SHI1IM1
G, Aa.i H, SAITO Y, KAMBAYASHI Y, INOUYE K, ET A: Receptor
selectivity of natriuretic peptide family, atrial natriuretic peptide,
brain natriuretic peptide, and C-type natriuretic peptide. Endocrinol-
ogy 130:229—239, 1992
2. DREWETr JG, GARBERS DL: The family of guanylyl cyclase receptors
and their ligands. Endocr Rev 15:135—62, 1994
3. GARBERS DL, KOESLING D, SCHULTZ G: Guanylyl cyclase receptors.
Mol Biol Cell 5:1—5, 1994
4. KOLLER U, LOWE DG, BENNETT GL, MINAMIN0 N, KANGAWA K,
MATSUO H, GOEDDEL DV: Selective activation of the B natriuretic
peptide receptor by C-type natriuretic peptide (CNP). Science 252:
120—123, 1991
5. STANTON BA: Molecular mechanisms of ANP inhibition of renal
sodium transport. Can J Physiol Pharmacol 69:1546—1552, 1991
6. GUNNING ME, BRENNER BM: Natriuretic peptides and the kidney:
Current concepts. Kidney mt 42(Suppl 38):S127—S133, 1992
7. NONOGUCHI H, SANDS JM, KNEPPER MA: ANF inhibits NaCI and fluid
absorption in cortical collecting duct of rat kidney. Am J Physiol
256:F179—F186, 1989
8. SUDOH T, MINAMINO N, KANGAWA K, MATSUO H: C-type natriuretic
peptide (CNP): A new member of natriuretic peptide family identified
in porcine brain. Biochem Biophys Res Commun 168:863—870, 1990
9. BROWN J, SALAS SP, SINGLETON A, POLAK JM, DOLLERY CT: Auto-
radiographic localization of atrial natriuretic peptide receptor sub-
types in rat kidney. Am J Physiol 259:F26—F39, 1990
10. NONOGUCHI H, KNEPPER MA, MANGANIELLO VC: Effects of atrial
natriuretic factor on cyclic guanosine monophosphate and cyclic
adenosine monophosphate accumulation in microdissected nephron
segments from rats. J Clin Invest 79:500—507, 1987
11. TERADA Y, MORIYAMA T, MARTIN BM, KNEPPER MA, GARCIA-
PEREZ A: RT-PCR microlocalization of mRNA for guanylyl cycla-
se-coupled ANF receptor in rat kidney. Am J Physiol 261:F1080—
F1087, 1991
12. BROWN J, Ziio Z: Renal receptors for atrial and C-type natriuretic
peptides in the rat. Am J Physiol 263:F89—F96, 1992
13. GILKES AF, OGDEN PH, GUILD SB, CRAMB G: Characterization of
natriuretic peptide receptor subtypes in the AtT-20 pituitary tumour
cell line. Biochem J 299:481—487, 1994
14. YAMAMOTO T, FENG L, MIzuNo T, HIROSE S, KAWA5AKI K, YAOITA
E, K1HARA I, WILSON CB: Expression of mRNA for natriuretic
peptide receptor subtypes in bovine kidney. Am J Physiol 267:F318—
F324, 1994
15. TERADA Y, TOMITA K, NONOGUCHI H, YANG T, MARUMO F: PCR
localization of C-type natriuretic peptide and B-type receptor mRNAs
in rat nephron segments. Am J Physiol 267:F215—F222, 1994
16. DEAN AD, VEHASKARI M, GREENWALD JE: Localization of the C-type
natriuretic peptide receptor, GC-B, in the rat kidney. (abstract) JAm
Soc Nephrol 5:657a, 1994
17. POTTER LR, GARBERS DL: Dephospholylation of the guanylyl cycla-
se-A receptor causes desensitization. J Biol Chem 267:14531—14534,
1992
18. HEMKEN P, Guo XL, WANG ZQ, ZHANG K, GLUCK 5: Immunologic
evidence that vacuolar H ATPases with heterogeneous forms of Mr
= 31,000 subunit have different membrane distributions in mamma-
lian kidney. J Biol C/tern 267:9948—9957, 1992
19. BASTANI B, PURCELL H, HEMKEN P, TRIGG D, GLUCK 5: Expression
and distribution of renal vacuolar proton-translocating adenosine
triphosphatase in response to chronic acid and alkali loads in the rat.
J Clin Invest 88:126—136, 1991
20. BROWN D, HIRSCH 5, GLUCK 5: Localization of a proton-pumping
ATPase in rat kidney. J C/in Invest 82:21 14—2126, 1988
21. BANKIR L, DE ROUFFIGNAC C: Urinary concentrating ability: Insights
from comparative anatomy. Am J Physiol 249:R643-R666, 1985
22. BROWN D, SABOLIC I, GLUCK S: Polarized targeting of V-ATPase in
kidney epithelial cells. J Exp Biol 172:231—243, 1992
23. VERLANDER JW, MADSEN KM, TI5HER CC: Structural and functional
features of proton and bicarbonate transport in the rat collecting duct.
Semin Nephrol 11:465—477, 1991
24. SCHUSTER VL: Function and regulation of collecting duct intercalated
cells. Annu Rev Physiol 55:267—288, 1993
25. BROWN D, HIRSCH S, GLUCK 5: An H-ATPase in opposite plasma
membrane domains in kidney epithelial cell subpopulations. Nature
331:622—624, 1988
26. ALPER SL, NATALE J, GLUCK 5, LODISH HF, BROWN D: Subtypes of
intercalated cells in rat kidney collecting duct defined by antibodies
against erythroid band 3 and renal vacuolar H-ATPase. Proc Nati
Acad Sci USA 86:5429—5433, 1989
27. EMMONS C, KURTZ I: Functional characterization of three intercalated
cell subtypes in the rabbit outer cortical collecting duct. J Clin Invest
93:417—423, 1994
28. NEEDLEMAN P, BLAINE EH, GREENWALD JE, MICHENER ML, SAPER
CB, STOCKMANN PT, TOLUNAY HE: The biochemical pharmacology of
atrial peptides. Annu Rev Pharmacol Toxicol 29:23—54, 1989
29. CLAVELL AL, STINGO AJ, WEI CM, HEUBLEIN DM, BURNETT J JR:
C-type natriuretic peptide: A selective cardiovascular peptide. Am J
Physiol 264:R290-R295, 1993
30. JAMISON RL, CANAAN-KUHL 5, Prr R: The natriuretic peptides and
their receptors. Am J Kidney Dis 20:519—530, 1992
31. BERTRAND P, DOBLE A: Degradation of atrial natriuretic peptides by
an enzyme in rat kidney resembling neutral endopeptidase 24.11.
Biochem Pharmacol 37:3817—3821, 1988
32. KENNY AJ, BOURNE A, INGRAM J: Hydrolysis of human and pig brain
natriuretic peptides, urodilatin, C-type natriuretic peptide and some
C-receptor ligands by endopeptidase-24.11. Biochem J 291:83—88,
1993
33. RITTER D, CHAO J, NEEDLEMAN P, TETENS E, GREENWALD JE:
Localization, synthetic regulation, and biology of renal atriopeptin-
like prohormone. Am J Physiol 263:F503—F509, 1992
1766 Ritter et al: Renal natriuretic peptide receptors
34. DEAN AD, VEHASKARI VM, GREEN WALD JE: Synthesis and localiza-
tion of C-type natriuretic peptide in mammalian kidney. Am J Physiol
266:F491—F496, 1994
35. SUZUKI E, HIRATA Y, HAYAKAWA H, OMATA M, KOJIMA M, KAN-
GAWA K, MINAMINO N, MATSUO H: Evidence for C-type natriuretic
peptide production in the rat kidney. Biochem Biophys Res Commun
192:532—538, 1993
36. TOTSUNE K, TAKAHASHI K, MURAKAMI 0, SATOH F, SONE M, SAITO T,
SASANO H, MouRl T, ABE K: Natriuretic peptides in the human
kidney. Hypertension 24:758—762, 1994
37. FIGUEROA CD, LEWIS HM, MACIVER AG, MACKENZIE JC, BHOOLA
KD: Cellular localisation of atrial natriuretic factor in the human
kidney. Nephrol Dial Transplant 5:25—31, 1990
38. MCKENZIE JC, Scor JN, INAGAMI T: lmmunohistochemical localiza-
tion of atrial natriuretic peptide in the developing and adult mamma-
lian kidney. Am JAnat 190:182—191, 1991
39. SCHUSTER VL: Cortical collecting duct bicarbonate secretion. Kidney
mt 40(Suppl 33):S47—S50, 1991
40. SCHUSTER VL: Cyclic adenosine monophosphate-stimulated bicar-
bonate secretion in rabbit cortical collecting tubules. J Clin Invest
75:2056—2064, 1985
41. SCHUSTER VL: Bicarbonate reabsorption and secretion in the cortical
and outer medullary collecting tubule. Semin Nephrol 10:139—147,
1990
42. HAYASHI M, YAMAJI Y, IY0RI M, KITAJIMA W, SARUTA T: Effect of
isoproterenol on intracellular pH of the intercalated cells in the rabbit
cortical collecting ducts. J Clin Invest 87:1153—1 157, 1991
43. HAYS 5, KOKKO JP, JACOBSON HR: Hormonal regulation of proton
secretion in rabbit medullary collecting duct. J Clin Invest 78:1279—
1286, 1986
44. JACOBSON HR, FURUYA H, BREYER MD: Mechanism and regulation
of proton transport in the outer medullary collecting duct. Kidney mt
40(Suppl 33):S51—S56, 1991
45. ToJo A, GUZMAN NJ, GARG LC, TISHER CC, MADSEN KM: Nitric
oxide inhibits bafilomycin-sensitive H(+)-ATPase activity in rat cor-
tical collecting duct. Am J Physiol 267:F509—F515, 1994
